Ibrutinib induces durable remissions in treatment-naïve patients with CLL and 17p deletion and/or TP53 mutations
Journal article published in 2021 by
Mariela Sivina 
,
Ekaterina Kim,
William G. Wierda,
Alessandra Ferrajoli,
Nitin Jain,
Philip Thompson,
Hagop Kantarjian ,
Michael Keating,
Jan A. Burger
,
Ekaterina Kim,
William G. Wierda,
Alessandra Ferrajoli,
Nitin Jain,
Philip Thompson,
Hagop Kantarjian ,
Michael Keating,
Jan A. Burger
This paper is made freely available by the publisher.
Full text: Download
Preprint: archiving forbidden
Published version:
archiving forbidden
Data provided by 